ZUMA-Workshop: Indikatoren einer "nachhaltigen Entwicklung"
TATuP Redaktion
doaj +1 more source
Clinical and Biological Correlates of Resistance and Relapse After CD19-Directed CAR T-Cell Therapy in Large B-Cell Lymphoma: A Structured Narrative Review. [PDF]
Resende JSS +5 more
europepmc +1 more source
Persistence of Covert but Not Overt Corrective Saccades in Darkness: Insights From Unilateral and Bilateral Vestibular Loss. [PDF]
Zuma E Maia F, Ramos BF.
europepmc +1 more source
Correction: Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies. [PDF]
Li P, Xue X, Zhang Z.
europepmc +1 more source
A patient's experience with follicular lymphoma from diagnosis to cure: the life-changing impact of CAR T-cell therapy. [PDF]
Adami L.
europepmc +1 more source
Health-related quality of life reporting in randomized controlled trials of chimeric antigen receptor T-cell therapy: A systematic review of dedicated publications. [PDF]
de Boissieu P, Lengliné E, Chevret S.
europepmc +1 more source
Navigating T-Cell-Directed Therapies in Transformed Follicular Lymphoma. [PDF]
Zelikson V, Karmali R.
europepmc +1 more source
B Cell Aplasia Following CAR T Cell Therapy: Incidence, Kinetics, Prognostic Implications, and Clinical Management. [PDF]
Khalifeh M, Surapaneni M, Salman H.
europepmc +1 more source

